Cangiano J L, Rodríguez-Sargent C, Martínez-Maldonado M
J Pharmacol Exp Ther. 1979 Feb;208(2):310-3.
The effects of pretreatment with hydralazine and alpha-methyldopa were assessed in rats made hypertensive by ligation of the left renal artery (LRA). Systolic blood pressure and peripheral renin activity (PRA) were measured 7 and 1 day before LRA and 2, 7 and 28 days after LRA. Systolic blood pressure increased 2 days after LRA in control and alpha-methyldopa-treated rats but not in the hydralazine-treated rats. Peripheral renin activity levels did not correlate with changes in systolic blood pressure. Peripheral renin activity first increased 7 days after LRA but decreased 28 days after LRA despite persistent hypertension in controls and alpha-methyldopa-treated rats. It is concluded that factors other than renin are involved in the initial and maintenance phases of this experimental model. In addition, hydralazine protects the rat with LRA from developing hypertension.
在通过结扎左肾动脉(LRA)使大鼠患高血压的实验中,评估了肼屈嗪和α-甲基多巴预处理的效果。在结扎左肾动脉前7天和1天以及结扎后2天、7天和28天测量收缩压和外周肾素活性(PRA)。在对照组和α-甲基多巴治疗的大鼠中,结扎左肾动脉后2天收缩压升高,但在肼屈嗪治疗的大鼠中未升高。外周肾素活性水平与收缩压变化不相关。尽管对照组和α-甲基多巴治疗的大鼠持续高血压,但外周肾素活性在结扎左肾动脉后7天首次升高,而在结扎后28天下降。得出的结论是,肾素以外的因素参与了该实验模型的初始和维持阶段。此外,肼屈嗪可保护结扎左肾动脉的大鼠不发生高血压。